News

Photo
07.10.2020 • News

Arkema Executives Acquitted in Crosby Case

A Texas judge has acquitted Arkema and three of its executives over an explosion and fire at the company’s facility in Crosby during Hurricane Harvey in August 2017.

Photo
06.10.2020 • News

K+S in Americas Sale Talks with Stone Canyon

Responding to market rumors, German potash and salt company K+S has confirmed it is in “very advanced negotiations” with US-based global industrial holding company Stone Canyon Industries Holdings about a potential sale of its Americas operating unit.

Photo
06.10.2020 • News

J&J Said to Pay $100 Million to Settle Talc Suits

Johnson & Johnson (J&J) has agreed to pay in excess of $100 million to resolve more than 1,000 class action lawsuits claiming its talc-based baby powder caused their cancer, the Bloomberg news agency has reported.

Photo
06.10.2020 • News

Total to Set up Bioplastics Hub in France

French energy and petrochemicals giant Total is planning to convert its Grandpuits refinery south of Paris into a zero-crude platform that will produce bioplastics as well as engage in chemical recycling of waste plastics. Two photovoltaic solar power plants will also be part of the project due to cost €500 million and be completed by 2024.

Photo
05.10.2020 • News

Showa Denko Merges European Units

Japan’s Showa Denko has decided to consolidate its two European subsidiaries to expand business operations in the region. Effective Jan. 1, 2021, Showa Denko Carbon Holding (SDCH) will take over Showa Denko Europe (SDE), becoming the surviving entity. It will then change its name to Showa Denko Europe.

Photo
05.10.2020 • News

LyondellBasell Buys Half of Sasol’s Lake Charles Site

LyondellBasell has agreed to pay $2 billion for a 50% stake in Sasol’s glitch-plagued production complex in Lake Charles, Louisiana, USA, The deal, scheduled to close at year’s end, includes joint ownership of the site’s new ethane cracker and downstream plastics production.

Photo
05.10.2020 • News

Roche Acquires Irish Biotech Inflazome

Swiss drugmaker Roche has acquired Irish biotech Inflazome for €380 million, said to be one of the largest deals in Irish biotech history. Headquartered in Dublin, Inflazome regards itself as a leader in the development of inflammasome inhibitors.

Photo
02.10.2020 • News

Siegfried to Buy Two Novartis Sites in Spain

Swiss CDMO Siegfried has signed a binding agreement with compatriot Novartis to acquire two pharmaceutical manufacturing sites in Spain. The Zofingen-based group said the buy will “significantly enhance” its global production network in terms of capacity and technological capabilities and will allow it to reach a critical size in finished dosage forms, thus creating further potential for profitable growth.

Photo
02.10.2020 • News

Covestro to Take DSM Coatings Resins

In a major move portfolio move, German engineering plastics producer Covestro is taking over DSM’s coating resins business for €1.6 billion, including debt. The transaction is expected to close in the first quarter of 2021, following all approvals.

Photo
01.10.2020 • News

AkzoNobel Ups Como Coatings Capacity

Paints and coatings group AkzoNobel is investing €20 million to expand capacity for automotive powder coatings at its site in Como, Italy. The company said the project will strengthen its market position and sharpen its focus on greener manufacturing.

Photo
01.10.2020 • News

Saudi Groups Start Merger Discussions

Resurrecting plans from nine years ago, National Petrochemical (Petrochem) and Saudi Industrial Investment Group (SIIG) have initiated discussions about the economic feasibility of a merger.

Photo
01.10.2020 • News

BASF Completes Construction Chemicals Sale

BASF completed the sale of its construction chemicals business to an affiliate of private equity investor Lone Star on the last day of September and the 2020 third quarter. Selling price was €3.17 billion.

Photo
30.09.2020 • News

Hexion Sells Resins Businesses to Private Equity

Hexion has agreed to sell its phenolic specialty resin, hexamine and European-based forest products resins businesses to private equity investors Investindustrial and Black Diamond Capital Management for approximately $425 million.

Photo
30.09.2020 • News

Sanofi Completes Principia Acquisition

French drugmaker Sanofi has completed its acquisition of US-based Principia Biopharma for $100 per share in cash. The takeover worth altogether $3.7 billion was sealed following expiration of the tender offer for all of Principia’s shares on Sept. 25.

Photo
30.09.2020 • News

Merck Serono Wins Patent Dispute With Biogen

The US Court of Appeals for the Federal Circuit on Sept. 28 set aside a decision of the US district court of New Jersey in Newark, reversing the district court’s earlier decision in favor of Biogen in a damages claim against Germany’s Merck Serono (known as EMD Serono in North America).

Photo
29.09.2020 • News

Messer Plans Spanish Gases Plant

German family owned industrial gases group Messer has announced plans to invest more than €35 million in a new plant in Vilaseca, Spain, which it said will lay down the foundation for further growth in Western Europe.

Photo
29.09.2020 • News

Scientists Urge Pfizer to Take Time With Vaccine

Only a few weeks ago, the race to bring Covid-19 vaccines was in high gear. Now some think the pace should be slower, amid AstraZeneca’s much commentated adverse event during its UK Phase 3 trial and US president Donald Trump’s haste to have a vaccine ready for deployment before the Nov.3 US elections.

Photo
29.09.2020 • News

Brenntag Splits into Two Divisions

Following an analysis of its internal structures and processes earlier this year, Brenntag will establish a new operating model with effect from January 2021, launching two global divisions – Brenntag Essentials and Brenntag Specialties.

Photo
28.09.2020 • News

Solvay Adapts European Peroxides Footprint

Solvay has announced it will reshuffle its hydrogen peroxide manufacturing network in Europe, the Middle East and Africa (EMEA) to meet a shift in demand, which has been accelerated by the coronavirus pandemic.

Photo
25.09.2020 • News

Air Liquide Builds China Gases Plant

French industrial gases group Air Liquide is spending about €60 million to build an air separation unit (ASU) in the Lingang Economic District, Tianjin Port Free Trade Zone, China. Air Liquide said it has been supplying industrial gases to this major industrial basin for more than 25 years and already operates seven production facilities there.

Photo
25.09.2020 • News

Polyplastics Plans German Polymers Plant

Japanese engineering plastics specialist Polyplastics has announced plans to build a cyclic olefin copolymer (COC) production plant in Leuna, Germany, to meet growing global demand for its Topas COC polymers.

Photo
25.09.2020 • News

Trump Says he Could Override FDA Vaccine Standards

US president Donald Trump has said he believes the White House could override the US Food and Drug Administration (FDA) if the national health watchdog goes ahead with mooted plans to toughen standards for approval of a Covid-19 vaccine or an Emergency Use Authorization.

Photo
24.09.2020 • News

Ineos Buys Renewable Electricity for Belgian Site

Olefins and polyolfins giant Ineos has signed an agreement to buy electricity from Belgian utility Engie’s Norther offshore wind farm in Belgium over a 10-year period. The contract is the largest ever-purchase contract of wind energy for heavy industry in Belgium, the Swiss-headquartered group said.

Photo
24.09.2020 • News

Evonik and Siemens Commission Photosynthesis Pilot

Evonik and Siemens Energy have commissioned a pilot plant that uses carbon dioxide (CO2) and water to produce chemicals. The plant is the culmination of two years’ work under the Rheticus I and II research projects to develop a technically feasible foundation for artificial photosynthesis using a bioreactor and electrolyzers.

Photo
23.09.2020 • News

Oqema Sets up new Distribution Partnership with Solvay

Global chemical company Solvay and specialty chemicals distributor Oqema have entered into a distribution partnership for phenol and phenol derivatives. The partnership covers Solvay’s products hydroquinone, methylhydroquinone, TBC and PTZ for the monomers market, alongside other phenol derivatives for the agrochemicals and pharma markets.

Photo
23.09.2020 • News

IMCD Takes Finland’s Kokko-Fiber

In its third purchase so far this month, IMCD has bought Kokko-Fiber, a Finnish supplier of fiber-reinforced plastic (FRP) composite materials. Financial details of the transaction were not disclosed. Earlier this month, IMCD also purchased Siyeza in South Africa and Indian excipients distributor Signet.

Photo
23.09.2020 • News

FDA may Issue Tougher EUA Standards

Amid worries in the American public that an unsafe vaccine could be approved by the US Food and Drug Administration just in time for the Nov. 3 election, the FDA reportedly will impose new, tougher, standards for an emergency authorization (EUA) of a coronavirus vaccine.

Photo
23.09.2020 • News

OQ Chemicals Licenses Technologies to Duqm

OQ Chemicals – formerly Oxea – has agreed to license its proprietary technology for the production of ethylene and propylene derivatives to Oman’s Duqm Refinery and Petrochemicals Industries Company (DRPIC).

Photo
22.09.2020 • News

Clariant Builds China Catalyst Plant

Clariant has announced it will build a new catalyst plant in China, its third in the country, as the Swiss group strives to strengthen its existing network.

Photo
22.09.2020 • News

Sanofi and GSK Ink EU Vaccine Deal

Sanofi and GSK have agreed a deal with the EU to supply up to 300 million doses of their recombinant protein-based Covd-19 vaccine pending regulatory approval, which is expected sometime in the first half of 2021.

Photo
22.09.2020 • News

BioNTech Acquiring Novartis’ Marburg Site

German biotech BioNTech has signed a share purchase agreement with Novartis to acquire the Swiss drugmaker’s GMP-certified manufacturing facility in Marburg, Germany. The deal will expand the Mainz-based company’s Covid-19 vaccine production capability by up to 750 million doses per year, or over 60 million doses per month, when fully operational.

Photo
21.09.2020 • News

Mylan Buys Aspen’s European Thrombosis Assets

Mylan has agreed to buy the related intellectual property and commercialization rights of Aspen Pharmacare’s European thrombosis business for €641.9 million. The company will use proceeds from the sale to pay down debt.

10602 more News

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.